Ablacon Company
Ablacon is a provider of AI-guided atrial fibrillation therapies.
Founded Date:
2015
Total Funding:
$6.8B
Investor Type:
contact@ablacon.com
Technology:
['BioTech & HealthTech']
Last Funding Type:
Post-IPO Equity
Investors Number:
7
Industry:
Med Tech
Headquarters:
Wheat Ridge, Colorado, United States
Estimated Revenue:
$50M to $100M